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Abstract. Tuberculosis (TB) caused by the bacterium Mycobacterium tuberculosis (Mtb), is curable 
disease which by only using a few new antibiotics. TB treatment has several stages, namely 
intensive and advanced stages. Compliance in taking Obat Anti Tuberkulosis (OAT) is an important 
factor to the success of TB treatment but the side effects of drugs make patients simply stopping 
treatment and it creates failure the TB treatment process. Improved adherence can do by using a 
fixed-dose combination OAT. In the intensive phase, the patient will get a fixed-dose combination 
containing a mixture of four antibiotics. The purpose of this study is to evaluate the potential side 
effects that occur during fixed-dose combination OAT treatment at an intensive stage and see the 
level of compliance of patients taking TB drugs. Observational sampling in TB patients was taking 
OAT at an acute stage by looking at side effects that arise during treatment and then analyzed using 
SPSS version 23 and Naranjo algorithm. The results showed the most common potential side effects 
for fixed-dose combination OAT in the intensive stage were itching, headache and nausea with a 
percentage of 72% each, joint pain 45%, stomach pain 36.4%, lack of appetite and rashes 27.3% 
each and reddish color in the urine 18.2%. The results of the analysis using Naranjo algorithm 
obtained results eight, which means the side effects might cause due to the use of the drug. The 
results of patient compliance achieved a 100% compliance rate. 
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INTRODUCTION 
 
Tuberculosis caused by Mycobacterium 
tuberculosis. Where these bacteria are acid-
resistant and most often attack the lungs even 
though other organs can attacked as well as 
bones, brain, kidneys, or lymph nodes [1,2]. 
Transmission of TB bacteria in two ways, 
namely directly or indirectly, into the 
respiratory tract [3]. Indonesia is one of the 
countries that have the most TB cases in the 
world, namely 10% of the pulmonary TB cases 
that occur in the world. According to WHO, the 
success rate of TB treatment is 85%, but 
Indonesia has not reached that percentage. The 
success rate of TB treatment in Indonesia is 
only 81.3%, or below the target of WHO [4]. 
The potential cause of increased side effects can 
occur due to consuming drugs regularly, drugs 
in more than one amount or polypharmacy, or 
treatment for an extended period, one of which 
is Tuberculosis. 
 
Tuberculosis is a disease that must treat with 
large amounts of antibiotics. TB treatment that 
commonly used today is a fixed-dose 
combination that aims to increase TB 
compliance because patients only consume one 
type of drug that contains several antibiotics. 
The occurrence of side effects can be a 
significant factor in the severance of TB 
treatment because OAT does have a variety of 
side effects [5]. The patient's level of adherence 
to undergoing treatment indicates the success 
rate of TB treatment. Side effects that arise, 
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lack awareness in patients, and the use of drugs 
in the long term is the cause of non-compliance 
with treatment. Because one of them is the side 
effects that cause medication noncompliance, 
the monitoring of side effects becomes very 
necessary. All TB patients who are currently 
undergoing treatment should inform of the 
potential side effects that may arise due to the 
use of TB drugs. Because many of the TB 
patients who drop out of treatment due to not 
resistant to side effects from OAT. Providing 
education about the side effects of OAT 
becomes very important so that patients remain 
obedient in consuming OAT even though after 
consumption, various side effects can occur, 
and TB patients do not stop treatment if there 
are events these side effects occur. According to 
the Indonesian Ministry of Health (2018), side 
effects from consuming OAT can occur either 
mild or severe. Potential side effects that may 
occur include nausea, vomiting, decreased 
appetite, hearing loss, visual disturbances, 
headaches, itching, joint pain, and redness in the 
urine 4. The study was conducted on 11 TB 
patients using intensive stage OAT, who met 
the inclusion criteria at Dr. Pirngadi Medan. 
Potential side effects that occur most in men at 
54.5%, the most age suffer from TB that is 18, 
24, and 31 years, respectively 18.2%. Most side 
effects that occurred in the first month were two 
side effects of 54.5%, and in the second month, 
the most were three side effects of 45.5%. 
Patient compliance in using OAT is 100%. 
 
METHODOLOGY 
 
This research used MESO sheets, Naranjo 
Algorithm sheets, and questionnaires to use 
compliance drug sheets. 
 
The study was a descriptive study that used a 
prospective observational method in sampling. 
Inclusion criteria included patients diagnosed 
with TB and received a fixed-dose combination 
OAT. The use of OAT in patients is monitored 
for two months and seen side effects that arise 
during the use of fixed-dose combination OAT 
from September to October 2018. Patients who 
sampled are patients who are willing to fill out 
informed consent and compliance 
questionnaires. The description of patient 
characteristics includes several criteria, namely, 
age, age, occupation, and life habits. Data 
analysis uses SPSS version 23. 
 
Data analysis of the side effects of anti-
tuberculosis drugs (ATDs) combined with a 
fixed-dose and level of compliance was 
descriptively using SPSS version 23. 
RESULTS AND DISCUSSION 
 
Patient characteristics from the medical records 
of patients were included in the inclusion 
criteria, as shown in Table 1. 
Table 1. Characteristic of Tuberculosis Patient 
Characteristic 
patient 
Amount 
(n) 
Percentage 
(%) 
Gender     
Male 6 54.5% 
Female 5 45.5% 
Age     
18 – 25 4 36.4% 
26 – 35 3 27.3% 
36 – 45 2 18.2% 
46 – 55 1 9.1% 
56 – 65 1 9.1% 
Occupation     
Work  6 54.5% 
Not work 5 45.5% 
Living habits     
Smoke 
not smoke  
6 
5 
54.5% 
45.5% 
Alcohol 
consumtion 
3 27.3% 
No alcohol 
consumtion 
8 73.7% 
 
Table 1 shows the characteristics of TB’s 
patient which most male patients descriptively 
suffering from tuberculosis (54.5%) with 
activities as workers (54.5%). The highest age 
of patients suffering from TB is 18, 24, and 31 
years (18.2%), with the habit of consuming 
cigarettes (54.5%), but most do not drink 
alcohol (73.7%). The incidence of TB suffering 
in both women and men is the same, but the 
increase in TB occurrence in men with age due 
to work and social environment makes it easier 
to exposed to TB germs where this study is 
following the review of Shamiya et al. (2015) 
which statesmen are more susceptible to TB. 
 
Smoking is a factor that speeds up a person's 
exposure to TB because toxic substances 
produced from burning cigarettes will produce 
free radicals that can reduce the body's defense 
system, especially the lung organs, where these 
organs are organs that are favored by TB germs 
[6]. TB will be nine times more likely to attack 
the respiratory tract in people who consume 
cigarettes. The incidence of latent TB will be 
two times greater when exposed to cigarette 
acid [7]. Nurjanah (2015) states the same thing 
that the most critical risk factor for contracting 
TB at a productive age is the habit of 
consuming cigarettes. TB often infects patients 
during a fertile period because they interact 
more frequently with unfavorable surroundings 
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[8]. TB incidence rates can increase in both 
active smokers and passive smokers because 
exposure to cigarette smoke can weaken the 
respiratory system, especially the lung organs. 
A person often has TB but does not realize it is 
called latent TB. Latent TB is TB that is already 
present in a person's body but does not yet cause 
symptoms, but if the person's immune system 
decreases, it can develop into active TB [9]. TB 
can infect a person unnoticed due to primary 
infection in childhood, which not handled 
correctly [2,10]. 
 
Table 2. Comparison between the drug side 
effects of TB patient's who use Anti-
Tuberculosis Drugs (ATDs) for one month and 
two month.  
 
Drug 
side 
effect 
Observation  
One month  Two month 
N % N % 
Itchy         
Yes 2 18,2% 8 72.7% 
No  9 81,8% 3 27.3% 
Headache         
Yes 6 54,5% 8 72.7% 
No 5 45,5% 3 27.3% 
Joint pain         
Yes 1 9,1% 5 45.5% 
No 10 90,9% 6 54.5% 
Reduced 
appetite 
        
Yes - - 3 27.3% 
No 11 100,0% 8 72.7% 
Nausea         
Yes 5 45,5% 8 72.7% 
No 6 54,5% 3 27.3% 
Blurred 
vision  
        
Yes - - - - 
No  11 100,0% 11 100.0% 
Stomach 
ache 
        
Yes 1 9,1% 4 36.4% 
No 10 90,9% 7 63.6% 
Rash         
Yes - - 3 27.3% 
No 11 100,0% 8 72.7% 
Reddish 
urine 
        
Yes - - 2 18.2% 
No 11 100,0% 9 81.8% 
 
Table 2 Results of interviews with TB patients 
every month for two months in TB patients 
taking fixed-dose OAT obtained data in the first 
month that most often appeared were 
complaints of headaches (54.5%) and nausea 
(45.5%). In the second month, the effects of 
charges on patients were itching (72.7%), 
headache (72.7%), nausea (72.7%). Fixed-dose 
ATDs consists of a combination of several TB 
drugs consisting of Rifampicin, Isoniazid, 
Pyrazinamide, and Ethambutol in one tablet 
preparation to increase TB patient compliance 
in taking medicine [11,12]. Fixed-dose 
combination OAT aims to simplify prescription 
medication, simplify drug management to 
prevent the occurrence of resistance due to the 
use of ATDs in a single form or monotherapy 
[13]. Other side effects that appeared in the first 
month were two side effects of 54.5%, while in 
the second month, most patients suffered three 
side effects of 45.5%. Side effects in the first 
month are itching, joint pain, and abdominal 
pain, while in the second month, besides those 
mentioned, there are more side effects of rashes 
and redness in the urine. Research conducted by 
Diana Sari (2014), from interviews with 
patients using ATDs, the frequency of 
occurrence of side effects in the initial month of 
use is nausea and dizziness. The use of ATDs 
for the second month only appeared complaints 
of nausea, dizziness, pain, and itching [14]. 
Potential side effects can appear even though 
the drug has used following the dosage and 
instructions for use. Possible side effects on the 
use of  ATDs greatly influenced by dosage, 
time of administration, age, nutritional status, 
and a history of diseases such as impaired liver 
function, impaired kidney function, or the 
presence of HIV [15]. The most common 
potential side effects for Isoniazid use are 
nausea, vomiting, and headaches. If there is 
nausea due to the use of Isoniazid, it can 
overcome by administering omeprazole or 
metoclopramide. 
 
Rifampicin can cause urine to be red and should 
consume on an empty stomach because of its 
increased bioavailability an empty stomach. 
Other side effects due to Rifampicin are nausea 
and vomiting and dizziness. Pyrazinamide also 
often causes nausea and vomiting, wherein 
Pirazinamide is a nicotinic acid derivative 
whose structure is similar to isoniazid. 
Ethambutol is bacteriostatic with side effects 
that often arise in the form of nausea, vomiting, 
headaches, and vision problems [11]. 
Ethambutol is an antibiotic used in ATDs, 
which is bacteriostatic. Adverse reactions 
depend on each individual where not all 
individuals experience side effects due to the 
use of ATDs [11,16]. In the method of fixed-
dose combination OAT, if side effects occur, it 
will be challenging to determine which side 
effects due to drugs because the fixed-dose 
combination OAT, especially at the intensive 
stage, uses four types of medications at once in 
one tablet. If severe side effects occur, such as 
decreased vision or blindness, the use of fixed-
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dose ATDs can be stopped and replaced with 
compact ATDs therapy [17]. 
 
Table 3. The assessment of causality Naranjo 
Algorithm on research subjects using anti-
tuberculosis drugs (ATDs) 
No 
Drug 
side 
effect 
Amount 
of 
patients 
Score 
Suspected 
drug 
1 Itchy 8 8 Isoniazid 
    
Ethambutol 
Rifampicin 
Pyrazinamide 
2 Headache 8 8 Ethambutol 
3 Nausea 8 8 Rifampicin 
    Isoniazid 
    
Ethambutol 
Pyrazinamide 
4 Joint pain 5 8 Pyrazinamide 
5 
Stomach 
ache 4 8 Rifampicin 
    Isoniazid 
    Ethambutol 
6 Rash 3 8 Pyrazinamide 
    Rifampicin 
7 
Reduced 
appetite 3 8 Isoniazid 
    Pyrazinamide 
    
Ethambutol 
Rifampicin 
8 
Reddish 
urine 2 8 Rifampicin 
9 
Blurred 
vision - - Ethambutol 
        Isoniazid 
 
Assessment of potential side effects often uses 
the Naranjo Algorithm scale, especially 
commonly used in Indonesia (Table 3). This 
algorithm measures side effects through a 
questionnaire. Researchers conducted 
interviews with patients, and after the results 
obtained, researchers will do the sum of each 
question point, and the results adjusted to the 
available score. Causality analysis is an 
evaluation of the causal relationship between 
the occurrence of side effects that occur with the 
use of drugs by the patient. Causality analysis 
uses Naranjo logarithms to individually 
evaluate patients with the treatment to be given 
[18]. The causality category based on WHO 
consists of several groups based on existing 
scores. Score 0 (doubtful), which means there 
are no side effects. A score of 1-4 (possible) 
means that the clinical condition that appears 
may be a side effect. A score of 5-8 (Probable) 
means that the possibility of an unwanted state 
is a side effect of a suspected drug, and a rating 
greater than or equal to 9 (definite) means that 
specific side effects will occur [1]. The result of 
the sum of the scores in the Naranjo logarithms 
in this study is a score of 8. The value is 
probable, which means it is likely a side effect 
of a suspected drug [19]. All side effects such as 
itching, headache, nausea, joint pain, abdominal 
pain, rashes, lack of appetite, redness in the 
urine have a score of 8. Undesirable conditions 
such as itching, nausea, lack of desire that arise 
may be a side effect of RHZE. Side effects from 
ethambutol may cause headaches, joint pain 
may be due to pyrazinamide side effects, rashes 
are possible side effects of pyrazinamide and 
rifampicin, and reddish urine are possible side 
effects from rifampicin. 
 
The number of patients who experienced 
nausea, headaches, and data was 72.7%, 
respectively, which experienced joint pain by 
45.6%, abdominal pain 36.4%, rashes, and lack 
of appetite 27.3% each and redness in urine by 
18.2%. 
 
Table 4. TB’s patient compliance data  
Level of compliance Percentage (%) 
Obey  100% 
Not obey  - 
 
Patients in this study were all compliant (100%) 
taking fixed-dose OAT even though side effects 
appeared during use (Table 4). The level of 
adherence to consume drugs becomes very 
important in handling TB. Fixed-dose 
combination OAT is a polypharmacy drug. 
Polypharmacy consists of several medications 
so that drug interactions are possible [20]. 
Compliance plays a significant role in the 
success of therapy. In TB, long-term drug 
consumption can reduce the level of adherence. 
Drug side effects are also a common cause of 
patients stopping treatment. If the use of OAT 
is irregular and does not correspond to the 
specified time; as a result, there is resistance to 
the bacteria that causes tuberculosis to the OAT 
consumed. When resistance occurs, the 
treatment will be more extended, and the 
number of tuberculosis-killing antibiotics will 
be more numerous, and the side effects caused 
greater [21,22]. 
 
CONCLUSION 
The study was only carried out in one outpatient 
setting, and the results cannot be generalized to 
all patients in all hospitals in North Sumatra. 
Based on the results of the dominant side 
effects that arise, namely, itching, headaches, 
and nausea that is the highest percentage 
(72.7%). Based on the results obtained from the 
level of adherence, the patient underwent 
intensive treatment very well and assessed the 
causality of the Naranjo algorithm regarding 
drug side effects obtained by a score of 8, which 
means that side effects might be caused by 
using ATDs. 
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